|
End-of-day quote
Shenzhen S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 33.77 CNY | -0.68% |
|
+0.33% | +0.66% |
| 09-04 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 09-04 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 15.15B 2.26B 1.97B 1.86B 1.69B 3.17B 217B 3.18B 22.29B 8.6B 110B 8.49B 8.3B 355B | P/E 2026 * |
29.1x | P/E 2027 * | -147x |
|---|---|---|---|---|---|
| Enterprise Value | 15.15B 2.26B 1.97B 1.86B 1.69B 3.17B 217B 3.18B 22.29B 8.6B 110B 8.49B 8.3B 355B | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 12x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.68% | ||
| 1 week | +0.33% | ||
| Current month | -6.48% | ||
| 1 month | -8.80% | ||
| 3 months | +1.05% | ||
| 6 months | +4.81% | ||
| Current year | +0.66% |
| 1 week | 33.23 |  | 34.55 |
| 1 month | 33.23 | | 38.8 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 62.5 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 10/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 10/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 30/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Jian Zhang
BRD | Director/Board Member | 70 | 30/06/2024 |
Han Xiong Li
CHM | Chairman | 52 | 10/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 10/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/01/26 | Buy | Director | 4,200 | 0.0010% | ||
| 24/11/25 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.68% | +0.33% | -42.76% | +64.09% | 2.26B | |
| -1.61% | -0.15% | +10.95% | +60.09% | 45.94B | |
| -1.02% | -1.90% | +36.59% | +99.64% | 37.22B | |
| +2.19% | +3.65% | +11.83% | +80.29% | 12.06B | |
| +1.32% | +2.09% | -11.51% | +12.41% | 11.74B | |
| -0.95% | 0.00% | +19.27% | +141.86% | 9.03B | |
| +0.39% | +2.39% | +31.05% | +39.38% | 7.36B | |
| +1.30% | +1.17% | +17.37% | +187.41% | 7.2B | |
| -0.06% | +2.97% | +39.67% | -18.37% | 7.15B | |
| +0.70% | +1.10% | -41.96% | +5.34% | 5.03B | |
| Average | +0.16% | +0.91% | +7.05% | +67.21% | 14.5B | |
| Weighted average by Cap. | -0.45% | +0.21% | +16.39% | +72.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 161M 141M 133M 120M 226M 15.46B 227M 1.59B 613M 7.86B 605M 592M 25.3B | 1.26B 188M 164M 155M 140M 263M 18.01B 264M 1.85B 714M 9.16B 705M 689M 29.47B |
| Net income | 526M 78.49M 68.44M 64.62M 58.68M 110M 7.53B 110M 774M 299M 3.83B 295M 288M 12.32B | -102M -15.22M -13.27M -12.53M -11.38M -21.32M -1.46B -21.41M -150M -57.93M -742M -57.17M -55.9M -2.39B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | CN¥33.77 | -0.68% | 5,274,145 |
| 17/09/26 | CN¥34.00 | +1.31% | 4,072,272 |
| 16/09/26 | CN¥33.56 | +0.69% | 3,186,116 |
| 15/09/26 | CN¥33.33 | -1.97% | 3,071,496 |
| 14/09/26 | CN¥34.00 | +1.01% | 3,928,759 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
